187 related articles for article (PubMed ID: 21899391)
1. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions.
Carrade DD; Affolter VK; Outerbridge CA; Watson JL; Galuppo LD; Buerchler S; Kumar V; Walker NJ; Borjesson DL
Cytotherapy; 2011 Nov; 13(10):1180-92. PubMed ID: 21899391
[TBL] [Abstract][Full Text] [Related]
2. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
[TBL] [Abstract][Full Text] [Related]
4. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
7. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
[TBL] [Abstract][Full Text] [Related]
8. Immune potential of allogeneic equine induced pluripotent stem cells.
Aguiar C; Theoret C; Smith O; Segura M; Lemire P; Smith LC
Equine Vet J; 2015 Nov; 47(6):708-14. PubMed ID: 25196173
[TBL] [Abstract][Full Text] [Related]
9. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats.
Ishikane S; Yamahara K; Sada M; Harada K; Kodama M; Ishibashi-Ueda H; Hayakawa K; Mishima K; Iwasaki K; Fujiwara M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2010 Nov; 49(5):753-61. PubMed ID: 20692268
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
[TBL] [Abstract][Full Text] [Related]
12. Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood.
Lee HJ; Kang KS; Kang SY; Kim HS; Park SJ; Lee SY; Kim KD; Lee HC; Park JK; Paik WY; Lee L; Yeon SC
J Vet Sci; 2016 Sep; 17(3):289-97. PubMed ID: 26726028
[TBL] [Abstract][Full Text] [Related]
13. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.
Colbath AC; Dow SW; Phillips JN; McIlwraith CW; Goodrich LR
Stem Cells Dev; 2017 Apr; 26(7):503-511. PubMed ID: 27958776
[TBL] [Abstract][Full Text] [Related]
14. Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.
Williams LB; Co C; Koenig JB; Tse C; Lindsay E; Koch TG
Front Vet Sci; 2016; 3():56. PubMed ID: 27500136
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
[TBL] [Abstract][Full Text] [Related]
16. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
[TBL] [Abstract][Full Text] [Related]
17. Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.
Williams LB; Russell KA; Koenig JB; Koch TG
BMC Vet Res; 2016 Mar; 12():45. PubMed ID: 26952099
[TBL] [Abstract][Full Text] [Related]
18. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
19. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
[TBL] [Abstract][Full Text] [Related]
20. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
Front Immunol; 2022; 13():871216. PubMed ID: 35572507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
